AMRX
Amneal Pharmaceuticals, Inc. Class A Common StockstockNASDAQ
At CloseNov 13, 2026 3:59:58 PM EST
21.38USD-1.498%(-0.32)1,717,835
Pre-marketNov 13, 2026 9:27:30 AM EST
21.40USD-1.382%(-0.30)
After-hoursNov 13, 2026 4:00:30 PM EST
21.38USD+0.023%(+0.00)
AMRX Financials
In Q3 FY 2026 (ended ), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) reported revenue of $862.68M, net income of −$21.7M, operating cash flow of $98.3M, and assets of $5.27B (filed ).
Loading financial flows…